Randomized Comparison of Low and Conventional Irradiance PDT for Skin Cancer

NCT02872909 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-01-04

Study results available
· View outcomes & findings →

Summary

This study aims to examine whether the pain of topical photodynamic therapy (PDT) is significantly different when using low irradiance ambulatory light emitting diode (LED) devices compared with conventional higher irradiance hospital based LED light sources when used for superficial non-melanoma skin cancer. The investigators are also investigating the phototoxicity and efficacy of each regime in this randomized assessor-blinded clinical trial.

Conditions

  • Non-melanoma Skin Cancer

Interventions

DEVICE

Ambulight (Ambicare Health)

battery-operated low irradiance red light LED ("skin cancer plaster")

Sponsors & Collaborators

  • Sally Ibbotson

    lead OTHER

Principal Investigators

  • Sally H Ibbotson, MD · University of Dundee

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2017-02-06
Completion
2017-02-06

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02872909 on ClinicalTrials.gov